100 results on '"Tornero, E."'
Search Results
2. A novel analytical methodology for the determination of hydroxy polycyclic aromatic hydrocarbons in breast and cow milk samples
- Author
-
Martin-Tornero, E., Luque-Uría, A., Durán-Merás, I., and Espinosa-Mansilla, A.
- Published
- 2020
- Full Text
- View/download PDF
3. Characteristics of prosthetic joint infections due to Enterococcus sp. and predictors of failure: a multi-national study
- Author
-
Tornero, E., Senneville, E., Euba, G., Petersdorf, S., Rodriguez-Pardo, D., Lakatos, B., Ferrari, M.C., Pilares, M., Bahamonde, A., Trebse, R., Benito, N., Sorli, L., del Toro, M.D., Baraiaetxaburu, J.M., Ramos, A., Riera, M., Jover-Sáenz, A., Palomino, J., Ariza, J., and Soriano, A.
- Published
- 2014
- Full Text
- View/download PDF
4. HPLC determination of serum pteridine pattern as biomarkers
- Author
-
Martín Tornero, E., Durán Merás, I., and Espinosa-Mansilla, A.
- Published
- 2014
- Full Text
- View/download PDF
5. A simple HPLC-ESI-MS method for the direct determination of ten pteridinic biomarkers in human urine
- Author
-
Jiménez Girón, A., Martín-Tornero, E., Hurtado Sánchez, M.C., Durán Merás, I., and Espinosa Mansilla, A.
- Published
- 2012
- Full Text
- View/download PDF
6. Time trends in the aetiology of prosthetic joint infections: a multicentre cohort study
- Author
-
Barcenilla, F., Pérez-Villar, F., Prats-Gispert, L., Cisterna, R., Ibarra, S., López, Í., Santamaría, J.M., Cabo, J., García, D., Lora-Tamayo, J., Murillo, O., Pedrero, S., Álvarez-Parrondo, S., Muedra-Font, R., Raya-Fernández, C., Rodríguez-Alonso, C., Moreno, A., Blanco-Martínez-de-Morentin, M.A., Cabo-Magadan, R., Combalia, A., García, S., Martínez-Pastor, J.C., Tornero, E., Merino-Pérez, J., Montejo, J.M., Alier, A., Horcajada, J.P., Plasencia, V., Puig, L., Auñon, Á., Blanco, A., García-Cañete, J., Sandoval, E., Fakkas-Fernández, M., Garcés-Zarzalejo, C., Fariñas-Alvarez, C., Fariñas, M.C., Martinez-Martinez, L., Salas-Venero, C., Cobo, J., Ruiz-Carbajosa, P., Jordán, M., Crusi, X., Marinescu, C., Montaner, F., Ramírez, A., Corona, P.S., Lung, M., Muniain-Ezcurra, M.Á., Peñas-Espinar, C., Suárez, A.I., Álvarez, R., Cordero, J.-A., López-Pliego, M., Palomino, J., Puente, A., Benito, N., Franco, M., Ribera, A., Soriano, A., Rodriguez-Pardo, D., Sorlí, L., Fresco, G., Fernández-Sampedro, M., Dolores del Toro, M., Guío, L., Sánchez-Rivas, E., Bahamonde, A., Riera, M., Esteban, J., Baraia-Etxaburu, J.M., Martínez-Alvarez, J., Jover-Sáenz, A., Dueñas, C., Ramos, A., Sobrino, B., Euba, G., Morata, L., Pigrau, C., Coll, P., Mur, I., and Ariza, J.
- Published
- 2016
- Full Text
- View/download PDF
7. KLIC-score for predicting early failure in prosthetic joint infections treated with debridement, implant retention and antibiotics
- Author
-
Tornero, E., Morata, L., Martínez-Pastor, J.C., Bori, G., Climent, C., García-Velez, D.M., García-Ramiro, S., Bosch, J., Mensa, J., and Soriano, A.
- Published
- 2015
- Full Text
- View/download PDF
8. P1.01-01 Frequency of Germline Mutations in Patients with Non-small Cell Lung Cancer (NSCLC) Harboring Actionable DRIVER Alterations (G-DRIVER)
- Author
-
Jové, M., Gausachs, M., Bosch-Barrera, J., Carcereny, E., Teule, A., Mosteiro, M., Pineda, M., Tornero, E., Palmero, R., Vilarino, N., Ruffinelli, J.C., Mesia, C., Saldaña, J., Cuellar, A., Brenes, J., Hernandez, A., Fina, C., Brunet, J., Domenech, M., Moran, T., Sais, E., Lazaro, C., and Nadal, E.
- Published
- 2023
- Full Text
- View/download PDF
9. Total hip arthroplasty in HIV-infected patients: a retrospective, controlled study
- Author
-
Tornero, E, García, S, Larrousse, M, Gallart, X, Bori, G, Riba, J, Rios, J, Gatell, J M, and Martinez, E
- Published
- 2012
- Full Text
- View/download PDF
10. 136P Germline testing in a cohort of malignant mesothelioma (G-MESO)
- Author
-
Nadal, E., Gausachs, M., Castillo, C., Teulé, A., Brenes, J., Jové, M., Palmero, R., Mosteiro, M., Padrones, S., Bosch-Barrera, J., Pineda, M., Tornero, E., Alay, A., Lopez-Doriga, A., Brao, I., Arellano, M., Brunet, J., and Lazaro, C.
- Published
- 2023
- Full Text
- View/download PDF
11. Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers
- Author
-
Blanco, I., Kuchenbaecker, K., Cuadras, D., Wang, X.S., Barrowdale, D., Garibay, G.R., Librado, P., Sanchez-Gracia, A., Rozas, J., Bonifaci, N., McGuffog, L., Pankratz, V.S., Islam, A., Mateo, F., Berenguer, A., Petit, A., Catala, I., Brunet, J., Feliubadalo, L., Tornero, E., Benitez, J., Osorio, A., Cajal, T.R.Y., Nevanlinna, H., Aittomaki, K., Arun, B.K., Toland, A.E., Karlan, B.Y., Walsh, C., Lester, J., Greene, M.H., Mai, P.L., Nussbaum, R.L., Andrulis, I.L., Domchek, S.M., Nathanson, K.L., Rebbeck, T.R., Barkardottir, R.B., Jakubowska, A., Lubinski, J., Durda, K., Jaworska-Bieniek, K., Claes, K., Maerken, T. van, Diez, O., Hansen, T.V., Jonson, L., Gerdes, A.M., Ejlertsen, B., Hoya, M. de la, Caldees, T., Dunning, A.M., Oliver, C., Fineberg, E., Cook, M., Peock, S., McCann, E., Murray, A., Jacobs, C., Pichert, G., Lalloo, F., Chu, C., Dorkins, H., Paterson, J., Ong, K.R., Teixeira, M.R., Teixeira, Hogervorst, F.B.L., Hout, A.H. van der, Seynaeve, C., Luijt, R.B. van der, Ligtenberg, M.J.L., Devilee, P., Wijnen, J.T., Rookus, M.A., Meijers-Heijboer, H.E.J., Blok, M.J., Ouweland, A.M.W. van den, Aalfs, C.M., Rodriguez, G.C., Phillips, K.A.A., Piedmonte, M., Nerenstone, S.R., Bae-Jump, V.L., O'Malley, D.M., Ratner, E.S., Schmutzler, R.K., Wappenschmidt, B., Rhiem, K., Engel, C., Meindl, A., Ditsch, N., Arnold, N., Plendl, H.J., Niederacher, D., Sutter, C., Wang-Gohrke, S., Steinemann, D., Preisler-Adams, S., Kast, K., Varon-Mateeva, R., Gehrig, A., Bojesen, A., Pedersen, I.S., Sunde, L., Jensen, U.B., Thomassen, M., Kruse, T.A., Foretova, L., Peterlongo, P., Bernard, L., Peissel, B., Scuvera, G., Manoukian, S., Radice, P., Ottini, L., Montagna, M., Agata, S., Maugard, C., Simard, J., Soucy, P., Berger, A., Fink-Retter, A., Singer, C.F., Rappaport, C., Geschwantler-Kaulich, D., Tea, M.K., Pfeiler, G., John, E.M., Miron, A., Neuhausen, S.L., Terry, M.B., Chung, W.K., Daly, M.B., Goldgar, D.E., Janavicius, R., Dorfling, C.M., Rensburg, E.J. van, Fostira, F., Konstantopoulou, I., Garber, J., Godwin, A.K., Olah, E., Narod, S.A., Rennert, G., Paluch, S.S., Laitman, Y., Friedman, E., Liljegren, A., Rantala, J., Stenmark-Askmalm, M., Loman, N., Imyanitov, E.N., Hamann, U., Spurdle, A.B., Healey, S., Weitzel, J.N., Herzog, J., Margileth, D., Gorrini, C., Esteller, M., Gomez, A., Sayols, S., Vidal, E., Heyn, H., Stoppa-Lyonnet, Leone, M., Barjhoux, L., Fassy-Colcombet, M., Pauw, A. de, Lasset, C., Ferrer, S.F., Castera, L., Berthet, P., Cornelis, F., Bignon, Y.J., Damiola, F., Mazoyer, S., Sinilnikova, O.M., Maxwell, C.A., Vijai, J., Robson, M., Kauff, N., Corines, M.J., Villano, D., Cunningham, J., Lee, A., Lindor, N., Lazaro, C., Easton, D.F., Offit, K., Chenevix-Trench, G., Couch, F.J., Antoniou, A.C., Pujana, M.A., BCFR, SWE-BRCA, KConFab Investigators, GEMO, Human genetics, CCA - Oncogenesis, Medical Oncology, Clinical Genetics, Suzuki, Hiromu, MUMC+: DA KG Lab Centraal Lab (9), RS: GROW - Oncology, RS: GROW - R4 - Reproductive and Perinatal Medicine, CCA -Cancer Center Amsterdam, ARD - Amsterdam Reproduction and Development, Human Genetics, Department of Obstetrics and Gynecology, Clinicum, Medicum, Haartman Institute (-2014), and Department of Medical and Clinical Genetics
- Subjects
single nucleotide ,Oncology ,Carcinogenesis ,TUBG1 ,Genes, BRCA2 ,Genes, BRCA1 ,Càncer d'ovari ,MODIFIERS ,Genome-wide association study ,Cell Cycle Proteins ,Breast cancer ,mammary glands ,Aetiology ,genes ,skin and connective tissue diseases ,Cancer ,Extracellular Matrix Proteins ,Hazard ratio ,CHIP-SEQ ,3. Good health ,ddc ,Hyaluronan Receptors ,Medicine ,Teixeira ,Human ,medicine.medical_specialty ,Evolution ,Science ,Non-P.H.S ,Single-nucleotide polymorphism ,Evolution, Molecular ,SDG 3 - Good Health and Well-being ,Ovarian cancer ,Genetics ,biochemistry ,Humans ,human ,CELL ,Polymorphism ,GENOME-WIDE ASSOCIATION ,medicine (all) ,Retrospective Studies ,Cancer och onkologi ,Prevention ,Mutació (Biologia) ,Biology and Life Sciences ,Molecular ,SWE-BRCA ,BRCA1 ,medicine.disease ,BRCA2 ,POLYMORPHISM ,Genes ,Genetic Loci ,Cancer and Oncology ,Mutation ,U.S. Gov't ,Bioinformatics ,medicine.disease_cause ,3123 Gynaecology and paediatrics ,Tubulin ,Tumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14] ,ELEMENTS ,2.1 Biological and endogenous factors ,CD44 ,Non-U.S. Gov't ,Aurora Kinase A ,Likelihood Functions ,Multidisciplinary ,Research Support, Non-U.S. Gov't ,agricultural and biological sciences (all) ,genetics and molecular biology (all) ,BCFR ,Nuclear Proteins ,Single Nucleotide ,Mammary Glands ,SURVIVAL ,kConFab Investigators ,Female ,Microtubule-Associated Proteins ,Research Article ,Antigens, CD44 ,aurora kinase A ,breast neoplasms ,carcinogenesis ,cell cycle proteins ,estrogen receptor alpha ,evolution, molecular ,extracellular matrix proteins ,female ,genetic loci ,genetic predisposition to disease ,humans ,likelihood functions ,mammary glands, human ,microtubule-associated proteins ,nuclear proteins ,polymorphism ,retrospective studies ,tubulin ,genes, BRCA1 ,genes, BRCA2 ,mutation ,biochemistry, genetics and molecular biology (all) ,SUSCEPTIBILITY LOCI ,General Science & Technology ,3122 Cancers ,Breast Neoplasms ,Biology ,Research Support ,Polymorphism, Single Nucleotide ,N.I.H ,GENETIC INTERACTION NETWORKS ,Càncer de mama ,EXPRESSION SIGNATURE ,Amino acid sequence ,Research Support, N.I.H., Extramural ,Internal medicine ,Seqüència d'aminoàcids ,evolution ,Genetic variation ,Journal Article ,medicine ,Genetic Predisposition to Disease ,ddc:610 ,molecular ,Antigens ,Mammary Glands, Human ,ddc:611 ,Intramural ,Estrogen Receptor alpha ,Extramural ,Mutation (Biology) ,Research Support, N.I.H., Intramural ,3111 Biomedicine ,GEMO ,Research Support, U.S. Gov't, Non-P.H.S - Abstract
While interplay between BRCA1 and AURKA-RHAMM-TPX2-TUBG1 regulates mammary epithelial polarization, common genetic variation in HMMR (gene product RHAMM) may be associated with risk of breast cancer in BRCA1 mutation carriers. Following on these observations, we further assessed the link between the AURKA-HMMR-TPX2-TUBG1 functional module and risk of breast cancer in BRCA1 or BRCA2 mutation carriers. Forty-one single nucleotide polymorphisms (SNPs) were genotyped in 15,252 BRCA1 and 8,211 BRCA2 mutation carriers and subsequently analyzed using a retrospective likelihood approach. The association of HMMR rs299290 with breast cancer risk in BRCA1 mutation carriers was confirmed: per-allele hazard ratio (HR) = 1.10, 95% confidence interval (CI) 1.04 - 1.15, p = 1.9 x 10(-4) (false discovery rate (FDR)-adjusted p = 0.043). Variation in CSTF1, located next to AURKA, was also found to be associated with breast cancer risk in BRCA2 mutation carriers: rs2426618 per-allele HR = 1.10, 95% CI 1.03 - 1.16, p = 0.005 (FDR-adjusted p = 0.045). Assessment of pairwise interactions provided suggestions (FDR-adjusted p(interaction) values greater than 0.05) for deviations from the multiplicative model for rs299290 and CSTF1 rs6064391, and rs299290 and TUBG1 rs11649877 in both BRCA1 and BRCA2 mutation carriers. Following these suggestions, the expression of HMMR and AURKA or TUBG1 in sporadic breast tumors was found to potentially interact, influencing patients survival. Together, the results of this study support the hypothesis of a causative link between altered function of AURKA-HMMR-TPX2-TUBG1 and breast carcinogenesis in BRCA1/2 mutation carriers. Funding Agencies|National Cancer Institute [UM1 CA164920]; Lithuania (BFBOCC-LT): Research Council of Lithuania grant [LIG-07/2012]; Hereditary Cancer Association (Paveldimo vezio asociacija); LSC grant [10.0010.08]; ESF [2009/0220/1DP/1.1.1.2.0/09/APIA/VIAA/016]; Liepajas municipal council; Cancer Association of South Africa (CANSA); Morris and Horowitz Familes Endowed Professorship; NEYE Foundation; Spanish Association against Cancer [AECC08, RTICC 06/0020/1060, FISPI08/1120]; Mutua Madrilena Foundation (FMMA); COH-CCGCRN: City of Hope Clinical Cancer Genetics Community Network from the National Cancer Institute and the Office of the Director, National Institutes of Health; Hereditary Cancer Research Registry from the National Cancer Institute and the Office of the Director, National Institutes of Health [RC4CA153828]; Fondazione IRCCS Istituto Nazionale Tumori; Cancer Research-United Kingdom grant [C12292/A11174, C1287/ A10118]; NHMRC Program Grant; DKFZ; European Union (European Social Fund-ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)-Research Funding Program of the General Secretariat for Research and Technology: ARISTEIA; European Social Fund; Cancer Research United Kingdom Grants [C1287/A10118, C1287/A11990]; National Institute of Health Research (NIHR) grant; NIHR grant; Royal Marsden NHS Foundation Trust; Cancer Research United Kingdom Grant [C5047/A8385]; University of Kansas Cancer Center [P30 CA168524]; Kansas Bioscience Authority Eminent Scholar Program; Chancellors Distinguished Chair in Biomedical Sciences Professorship; AKG [5U01CA113916, R01CA140323]; German Cancer Aid [109076]; Center for Molecular Medicine Cologne (CMMC); Ligue National Contre le Cancer; Association "Le cancer du sein, parlonsen!" Award; Canadian Institutes of Health Research; Fund for Scientific Research Flanders (FWO); National Cancer Institute grant [CA 27469]; GOG Statistical and Data Center [CA 37517]; GOGs Cancer Prevention and Control Committee [CA 101165]; Intramural Research Program, NCI; ISCIII (Spain) [RD12/00369/0006, 12/00539]; European Regional Development FEDER funds; Helsinki University Central Hospital Research Fund; Academy of Finland [132473]; Finnish Cancer Society; Sigrid Juselius Foundation; Dutch Cancer Society grant [NKI1998-1854, NKI2004-3088, NKI2007-3756]; Netherlands Organization of Scientific Research [NWO 91109024]; Pink Ribbon grant [110005]; BBMRI grant [NWO 184.021.007/CP46]; Hungarian Research Grant [KTIA-OTKA CK-80745]; Norwegian EEA Financial Mechanism [HU0115/NA/2008-3/OP-9]; Spanish Ministry of Health ISCIII FIS [PI10/01422, PI12/01528, PI13/00285]; RTICC [RD12/0036/0008]; Ramon Areces (XV) Foundation; Eugenio Rodriguez Pascual Foundation; Roses Contra el Cancer Foundation; Spanish Association Against Cancer (AECC); AGAUR Generalitat de Catalunya [2009-SGR290, 2009-SGR293]; Polish Foundation of Science; Icelandic Association "Walking for Breast Cancer Research"; Nordic Cancer Union; Landspitali University Hospital Research Fund; Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program; Canadian Breast Cancer Research Alliance-grant [019511]; Ministry of Economic Development, Innovation and Export Trade-grant [PSR-SIIRI-701]; Ministero dellIstruzione, dellUniversita e della Ricerca and Ministero della Salute; Liga Portuguesa Contra o Cancro; National Breast Cancer Foundation; National Health and Medical Research Council (NHMRC); Queensland Cancer Fund; Cancer Council of New South Wales; Cancer Council of Victoria; Cancer Foundation of Western Australia; Cancer Councils of Tasmania; National Institutes of Health grant [CA128978]; NCI Specialized Program of Research Excellence (SPORE) in Breast Cancer [CA116201]; United States Department of Defence Ovarian Cancer Idea award [W81XWH-10-1-0341]; Breast Cancer Research Foundation; Jewish General Hospital Weekend; Quebec Ministry of Economic Development, Innovation and Export Trade; Cancer Councils of South Australia; European Regional Development Fund; State Budget of the Czech Republic (RECAMO) [CZ.1.05/2.1.00/03.0101]; MH CZ-DRO (MMCI) [00209805]; Niehaus Family Genetics Research Fund; STARR Cancer Consortium Grant; NAROD [1R01 CA149429-01]; NCI Intramural Research Program, National Institutes of Health [NO2-CP-11019-50, N02-CP-65504]; Westat, Inc, Rockville, Maryland; Clalit Health Services in Israel; Israel Cancer Association; Breast Cancer Research Foundation (BCRF), New York; Russian Federation for Basic Research [11-04-00227, 12-04-00928, 12-04-01490]; Federal Agency for Science and Innovations, Russia [02.740.11.0780]; Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program and grant from the National Cancer Institute [UM1 CA164920]; Breast Cancer Family Registry (BCFR); United States Government or the BCFR; Ohio State University Comprehensive Cancer Center; Isreal cancer association; Israeli Inherited breast cancer consortium; Swedish Cancer Society; Ralph and Marion Falk Medical Research Trust; Entertainment Industry Fund National Womens Cancer Research Alliance; National Institutes of Health (NIH) [R01-CA102776, R01-CA083855]; Rooney Family Foundation; Susan G. Komen Foundation for the cure, Basser Research Center; American Cancer Society Early Detection Professorship [SIOP-06-258-01-COUN]; SAF2010-20493; [PBZ_KBN_122/P05/2004]
- Published
- 2015
- Full Text
- View/download PDF
12. Assessing associations between the AURKAHMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers
- Author
-
Blanco, I, Kuchenbaecker, K, Cuadras, D, Wang, X, Barrowdale, D, De Garibay, GR, Librado, P, Sánchez-Gracia, A, Rozas, J, Bonifaci, N, McGuffog, L, Pankratz, VS, Islam, A, Mateo, F, Berenguer, A, Petit, A, Català, I, Brunet, J, Feliubadaló, L, Tornero, E, Benítez, J, Osorio, A, Teresa, R, Teresa, C, Nevanlinna, H, Aittomäki, K, Arun, BK, Toland, AE, Karlan, BY, Walsh, C, Lester, J, Greene, MH, Mai, PL, Nussbaum, RL, Andrulis, IL, Domchek, SM, Nathanson, KL, Rebbeck, TR, Barkardottir, RB, Jakubowska, A, Lubinski, J, Durda, K, Jaworska-Bieniek, K, Claes, K, Van Maerken, T, Díez, O, Hansen, TV, Jønson, L, Gerdes, AM, Ejlertsen, B, De La Hoya, M, Caldés, T, Dunning, AM, Oliver, C, Fineberg, E, Cook, M, Peock, S, McCann, E, Murray, A, Jacobs, C, Pichert, G, Lalloo, F, Chu, C, Dorkins, H, Paterson, J, Ong, KR, Teixeira, MR, Teixeira, T, Hogervorst, FBL, Van Der Hout, AH, Seynaeve, C, Van Der Luijt, RB, Ligtenberg, MJL, Devilee, P, Wijnen, JT, Rookus, MA, Meijers-Heijboer, HEJ, Blok, MJ, Van Den Ouweland, AMW, Aalfs, CM, Rodriguez, GC, Phillips, KAA, Piedmonte, M, Nerenstone, SR, Bae-Jump, VL, O'Malley, DM, Ratner, ES, Schmutzler, RK, Wappenschmidt, B, Rhiem, K, Engel, C, Meindl, A, Ditsch, N, Arnold, N, Plendl, HJ, Niederacher, D, Sutter, C, and Wang-Gohrke, S
- Subjects
skin and connective tissue diseases - Abstract
While interplay between BRCA1 and AURKA-RHAMM-TPX2-TUBG1 regulates mammary epithelial polarization, common genetic variation in HMMR (gene product RHAMM) may be associated with risk of breast cancer in BRCA1 mutation carriers. Following on these observations, we further assessed the link between the AURKA-HMMR-TPX2-TUBG1 functional module and risk of breast cancer in BRCA1 or BRCA2 mutation carriers. Forty-one single nucleotide polymorphisms (SNPs) were genotyped in 15,252 BRCA1 and 8,211 BRCA2 mutation carriers and subsequently analyzed using a retrospective likelihood approach. The association of HMMR rs299290 with breast cancer risk in BRCA1 mutation carriers was confirmed: per-allele hazard ratio (HR) = 1.10, 95% confidence interval (CI) 1.04 - 1.15, p = 1.9 × 10-4(false discovery rate (FDR)-adjusted p = 0.043). Variation in CSTF1, located next to AURKA, was also found to be associated with breast cancer risk in BRCA2 mutation carriers: rs2426618 per-allele HR = 1.10, 95% CI 1.03 - 1.16, p = 0.005 (FDR-adjusted p = 0.045). Assessment of pairwise interactions provided suggestions (FDR-adjusted pinteractionvalues > 0.05) for deviations from the multiplicative model for rs299290 and CSTF1 rs6064391, and rs299290 and TUBG1 rs11649877 in both BRCA1 and BRCA2 mutation carriers. Following these suggestions, the expression of HMMR and AURKA or TUBG1 in sporadic breast tumors was found to potentially interact, influencing patients' survival. Together, the results of this study support the hypothesis of a causative link between altered function of AURKA-HMMR-TPX2-TUBG1 and breast carcinogenesis in BRCA1/2 mutation carriers.
- Published
- 2015
- Full Text
- View/download PDF
13. Identification of a founder BRCA1 mutation in the Moroccan population.
- Author
-
Quiles, F., Teulé, À., Martinussen Tandstad, N., Feliubadaló, L., Tornero, E., Valle, J., Menéndez, M., Salinas, M., Wethe Rognlien, V., Velasco, A., Izquierdo, A., Capellá, G., Brunet, J., and Lázaro, C.
- Subjects
BRCA genes ,MUTAGENESIS ,FOUNDER effect ,BREAST cancer patients ,GENETICS of disease susceptibility ,PUBLIC health - Abstract
Breast cancer ( BC) is the most frequent cancer among women in Morocco. However, the role of the most prevalent BC-predisposing genes, BRCA1 and BRCA2, has been largely unexplored. To help define the role of BRCA1 in BC in Morocco, we characterized the first potential BRCA1 founder mutation in this population. Genetic testing of BRCA1 and BRCA2 in BC high-risk families identified mutation BRCA1 c. 5309G>T, p.( Gly1770Val) or G1770V in five independent families from Morocco, suggesting a founder effect. To confirm this hypothesis, haplotype construction was performed using seven intragenic and flanking BRCA1 microsatellite markers. Clinical data were also compiled. Clinical data from carriers of mutation G1770V correspond to data from carriers of BRCA1 pathogenic mutations. Microsatellite analysis showed a common haplotype for the five families in a region comprising 1.54 Mb, confirming G1770V as the first specific founder BRCA1 mutation in the Moroccan population. Our findings contribute to a better understanding of BC genetics in the Moroccan population. Nevertheless, comprehensive studies of mutation G1770V in large series of BC patients from Morocco are needed to assess the real prevalence of this mutation and to improve genetic testing and risk assessment in this population. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
14. Prosthetic joint infection due to Enterococcus sp treated with debridement, antibiotics and retention of the implant (DAIR)
- Author
-
Tornero, E. and Soriano, A.
- Published
- 2015
- Full Text
- View/download PDF
15. NIRS potential use for the determination of natural resources quality from dehesa (acorn and grass) in Montanera system for Iberian pigs.
- Author
-
Tejerina, D., García-Torres, S., Martín-Tornero, E., Gordillo, A., Ortiz, A., Ferraz-de-Oliveira, M. I., Machado, G., Sales-Baptista, E., Cabeza de Vaca, M., and Romero-Fernández, M. P.
- Subjects
MEAT quality ,SWINE nutrition ,NEAR infrared spectroscopy - Abstract
Copyright of Archivos de Zootecnia is the property of Archivos de Zootecnia and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2018
16. Comparison of procoagulatory markers in function of anesthesic/analgesic technique used on the surgery of traumathology prosthesis replacement.
- Author
-
Tonal, B. Gutiérrez, de la Fuente Tornero, E., Martínez, I. Garutti, Martínez, M. Villanueva, and Huerta, A. Rodríguez
- Published
- 2008
17. TREATMENT CHANGE IN ADOLESCENTS WITH SOCIAL ANXIETY DISORDER: INSIGHTS FROM CORPUS LINGUISTICS.
- Author
-
J. Garcia-Lopez, L., B. Díez-Bedmar, M., Pérez-Paredes, P., and Tornero, E.
- Subjects
- *
SOCIAL anxiety , *ANXIETY in adolescence , *TREATMENT effectiveness , *CORPORA , *PSYCHOLINGUISTICS , *SOCIAL psychology , *THERAPEUTICS - Abstract
Despite the efforts made in Clinical Psychology, the remission rates of social anxiety disorder are still moderate, which might stem from a lack of sensitivity in the psychological treatment outcome measures. New interdisciplinary perspectives such as the joint efforts of Corpus Linguistics and Psychology are, therefore, being sought. The purpose of this study is to explore if the linguistic insights provided by Corpus Linguistics are of any help when assessing sensitivity on treatment in adolescents with generalized social anxiety disorder. Results revealed the relevance of analysing adolescents' written texts for treatment outcome analysis by examining adolescents' texts based on the triple-response-system approach (cognitive, somatic and behavioural symptoms) and the DSM criteria for social anxiety disorder. The findings of this interdisciplinary paper are consistent with the DSM-V criteria in the proposed revision for social anxiety disorder. [ABSTRACT FROM AUTHOR]
- Published
- 2011
18. TP53 germline testing and hereditary cancer: how somatic events and clinical criteria affect variant detection rate.
- Author
-
Rofes P, Castillo-Manzano C, Menéndez M, Teulé Á, Iglesias S, Munté E, Ramos-Muntada M, Gómez C, Tornero E, Darder E, Montes E, Valle L, Capellá G, Pineda M, Brunet J, Feliubadaló L, Del Valle J, and Lázaro C
- Subjects
- Humans, Female, Male, Adult, Middle Aged, Adolescent, Young Adult, Tumor Suppressor Protein p53 genetics, Germ-Line Mutation, Li-Fraumeni Syndrome genetics, Li-Fraumeni Syndrome diagnosis, Genetic Predisposition to Disease, Genetic Testing methods
- Abstract
Background: Germline heterozygous pathogenic variants (PVs) in TP53 cause Li-Fraumeni syndrome (LFS), a condition associated with increased risk of multiple tumor types. As the associated cancer risks were refined over time, clinical criteria also evolved to optimize diagnostic yield. The implementation of multi-gene panel germline testing in different clinical settings has led to the identification of TP53 PV carriers outside the classic LFS-associated cancer phenotypes, leading to a broader cancer phenotypic redefinition and to the renaming of the condition as "heritable TP53-related cancer syndrome" (hTP53rc). Germline TP53 variant interpretation is challenging due to the diverse nature of TP53 PVs, variable penetrance of the syndrome, possible occurrence of TP53 somatic mosaicism, and TP53 involvement in clonal hematopoiesis of indeterminate potential (CHIP). Here we aim to assess the relevance and impact of these issues on the diagnostic routine, and to evaluate the sensitivity of the different LFS clinical criteria to identify hTP53rc., Methods: TP53 was analyzed in 6161 suspected hereditary cancer non-related patients categorized into three subgroups: (1) 495 patients fulfilling any LFS/Chompret clinical criteria; (2) 2481 patients diagnosed with early-onset breast/colorectal cancer; (3) 3185 patients without clinical criteria suggestive of hTP53rc. Ancillary tests were performed when TP53 PVs were identified in individuals not meeting LFS/Chompret criteria and/or when the variant was identified at low variant allele frequency (VAF)., Results: TP53 PVs were identified in blood DNA of 45 probands. Variant origin was elucidated in 39 of these: 72% patients had a constitutional PV, 10% were mosaics, and 18% had CHIP-associated PVs. Notably, two of the seven CHIP-TP53 PVs identified were detected at high allelic frequencies (VAF > 35%). Twenty-nine percent of germline TP53 PV did not meet any of the LFS clinical criteria. Among the clinical criteria, Chompret 2009 showed the highest sensitivity in our cohort (68% vs. 54% for Chompret 2015), highlighting the relevance of considering lung cancer in the criteria., Conclusions: Our data supports performing TP53 ancillary testing for the identification of potential mosaicisms and CHIP-associated PVs, particularly in patients not meeting clinical criterial for LFS, irrespective of the VAF, and the application of clinical criteria that include lung cancer diagnosis., Competing Interests: Declarations. Ethics approval and consent to participate: The research was conducted in accordance with the principles of the Declaration of Helsinki, and ethical approval was obtained from the ethics committee of Bellvitge Biomedical Research Institute (IDIBELL; PR278/19). Informed written consent for both diagnostic and research purposes was obtained from all participants. Consent for publication: Written informed consent for publication was obtained from all study participants. Competing interests: The authors declare no competing interests., (© 2025. The Author(s).)
- Published
- 2025
- Full Text
- View/download PDF
19. vaRHC: an R package for semi-automation of variant classification in hereditary cancer genes according to ACMG/AMP and gene-specific ClinGen guidelines.
- Author
-
Munté E, Feliubadaló L, Pineda M, Tornero E, Gonzalez M, Moreno-Cabrera JM, Roca C, Bales Rubio J, Arnaldo L, Capellá G, Mosquera JL, and Lázaro C
- Subjects
- Humans, United States, Genetic Testing, Genetic Predisposition to Disease, Bayes Theorem, Genome, Human, Automation, Genetic Variation, Neoplasms genetics
- Abstract
Motivation: Germline variant classification allows accurate genetic diagnosis and risk assessment. However, it is a tedious iterative process integrating information from several sources and types of evidence. It should follow gene-specific (if available) or general updated international guidelines. Thus, it is the main burden of the incorporation of next-generation sequencing into the clinical setting., Results: We created the vaRiants in HC (vaRHC) R package to assist the process of variant classification in hereditary cancer by: (i) collecting information from diverse databases; (ii) assigning or denying different types of evidence according to updated American College of Molecular Genetics and Genomics/Association of Molecular Pathologist gene-specific criteria for ATM, CDH1, CHEK2, MLH1, MSH2, MSH6, PMS2, PTEN, and TP53 and general criteria for other genes; (iii) providing an automated classification of variants using a Bayesian metastructure and considering CanVIG-UK recommendations; and (iv) optionally printing the output to an .xlsx file. A validation using 659 classified variants demonstrated the robustness of vaRHC, presenting a better criteria assignment than Cancer SIGVAR, an available similar tool., Availability and Implementation: The source code can be consulted in the GitHub repository (https://github.com/emunte/vaRHC) Additionally, it will be submitted to CRAN soon., (© The Author(s) 2023. Published by Oxford University Press.)
- Published
- 2023
- Full Text
- View/download PDF
20. Can the intra-operative measurement of the diameter of the femoral head help surgeons to choose the best size of the acetabular cup?
- Author
-
Muñoz-Mahamud E, Chimeno C, Tornero E, Alías A, Fernández-Valencia JÁ, and Combalia A
- Subjects
- Humans, Femur Head surgery, Acetabulum diagnostic imaging, Acetabulum surgery, Femur, Arthroplasty, Replacement, Hip adverse effects, Surgeons
- Abstract
Purpose: We hypothesized that the intra-operative measurement of the femoral head may increase the accuracy of the acetabular cup size optimal selection in total hip arthroplasty (THA). The purpose of this clinical research was to analyze the correlation between the estimated cup size from intra-operative measurement of the femoral head and the pre-operative templated cup size., Methods: A prospective observational single-center study was conducted from June 2019 to January 2020 including primary THA (n = 100). All cases were pre-operatively templated. The measurement of the anterior-posterior diameter of the femoral head was routinely intra-operatively performed. Any definitive implanted cup was considered as "oversized" when the size was > 4 mm than the diameter of the native head., Results: The median (interquartile range) size of the implanted cup, pre-operative planned cup size, and diameter of the femoral head were measured 52 (50-54) mm, 50 (48-54) mm and 49 (45-51) mm, respectively. Pre-operative planned size cup accurately predicted the implanted cup or differed in only one size (2 mm) in 77 (78%) cases. Otherwise, intra-operative femoral head measurement method accurately predicted the implanted or differed in only one size (2 mm) in 51 (87%) cases (p = 0.097)., Conclusion: The intra-operative femoral head measurement is a simple and reliable tool to help the surgeons choose the best size of the acetabular cup and is as reliable as the pre-operative templating in order to avoid cup oversizing in THA. Utmost caution is warranted whenever the cup reamer is > 4 mm than the anterior-posterior diameter of the native head., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
21. Fluorescence Monitoring Oxidation of Extra Virgin Olive Oil Packed in Different Containers.
- Author
-
Martín-Tornero E, Fernández A, Durán-Merás I, and Martín-Vertedor D
- Subjects
- Olive Oil chemistry, Oxidation-Reduction, Least-Squares Analysis, Spectrometry, Fluorescence methods, Multivariate Analysis, Plant Oils chemistry
- Abstract
'Picual' olive oil was stored in different types of containers for 10 months and monitored via quality parameters. In combination with the mentioned analysis, non-destructive fluorescence spectroscopy was performed combined with multivariate analysis to monitor and quantify oil quality levels. Excitation emission matrices (EMMs) were analyzed using parallel factor analysis (PARAFAC). According to the quality parameters, it was observed that Transparent Crystal (TC) and Opaque Crystal (OC) samples were the ones that deteriorated faster due to their higher exposure to light in comparison with Plastic (P) and Canned (C) samples. In a fast and non-destructive manner, the fluorescence spectroscopy-based prototype successfully monitored the oxidation changes in the EVOOs. Unfolded partial least squares (U-PLS) was used to generate a regression model to quantify quality parameters. Good correlation coefficients were found for the peroxide index, K
232 and the oxidative stability index (r2 between 0.90 and 0.94 for cross-validation and validation). For all of that, the results obtained confirmed the ability of fluorescence spectroscopy to monitor the quality of olive oil and EEMs combined with U-PLS can be used to analyze these parameters, eluding the classical methods.- Published
- 2022
- Full Text
- View/download PDF
22. Clinical and Radiological Outcome in a Series of Patients Treated by Anterior Cervical Discectomy and Fusion: Retrospective Controlled Study With 2 Different Stand-Alone Cages.
- Author
-
Poblete J, Martinez-Anda JJ, Rebollar-Mendoza AA, Castro-Moreno Y, Torne R, Reyes L, Fuster S, Tornero E, Arch-Tirado E, Leo-Vargas R, Combalia A, and Enseñat J
- Abstract
Background: Cervical spine balance and alignment targets after cervical spine surgery are poorly established in patients with cervical spine degenerative disease surgically treated by anterior cervical discectomy and fusion (ACDF). The objective of the study is to determine the correlation between radiological and clinical outcomes in patients surgically treated by ACDF with 2 different stand-alone cervical cages., Methods: Clinical outcomes were evaluated using visual analog scale (VAS), Neck Disability Index (NDI), Nurick Scale, and Japanese Orthopedic Association score for myelopathy. Radiological evaluation included cervical and segmental Cobb angles, cervical sagittal vertical axis (cSVA), T1 slope (T1s), C0-C2 angle, fusion rates, adjacent segment degeneration, and cage subsidence., Results: A total of 80 patients were included with an average age of 53 years. There was a statistically significant improvement in both clinical and radiological evaluations. There was a statistical significant correlation between cervical pain on cervical VAS and cSVA. There was a significant correlation between postoperative T1s and cSVA, related to the improvement in cervical angles. There was no significant difference in rates of fusion, adjacent segment changes, or reoperation between both cervical cages, and there was a higher rate of subsidence in the Aleutian group. There were significant differences between both groups on postoperative NDI and VAS, but this difference is not maintained during follow-up., Conclusions: Cervical sagittal balance is directly related to clinical outcome in patients with cervical spine degenerative disease. Both cervical implants analyzed were comparable in clinical and radiological outcomes., Clinical Relevance: There are important clinical and radiological parameters that should be taken into account for the analysis of the surgical outcome of patients treated by ACDF; this is one of the few studies that report the results with 2 different cervical cage designs., Competing Interests: Declaration of Conflicting Interests: The authors report no conflicts of interest in this work., (This manuscript is generously published free of charge by ISASS, the International Society for the Advancement of Spine Surgery. Copyright © 2022 ISASS. To see more or order reprints or permissions, see http://ijssurgery.com.)
- Published
- 2022
- Full Text
- View/download PDF
23. Application of Digital Olfaction for Table Olive Industry.
- Author
-
Sánchez R, Fernández A, Martín-Tornero E, Meléndez F, Lozano J, and Martín-Vertedor D
- Subjects
- Fermentation, Food Microbiology, Smell, Taste, Olea chemistry
- Abstract
The International Olive Council (IOC) established that olives must be free of odors, off-flavors, and absent of abnormal ongoing alterations or fermentations. The use of electronic devices could help when classifying defects in a fast, non-destructive, cheap, and environmentally friendly way. For all of that, table olives were evaluated according to IOC regulation in order to classify the defect predominant perceiving (DPP) of the table olives and their intensity. Abnormal fermentation defects of Spanish-style table olives were assessed previously by an IOC-validated tasting panel. 'Zapateria', 'Putrid', and 'Butyric' were the defects found at different concentrations. Different volatile compounds were identified by gas chromatography in altered table olives. The same samples were measured with an electronic nose device (E-nose). E-nose data combined with chemometrics algorithms, such as PCA and PLS-DA, were able to successfully discriminate between healthy and non-healthy table olives, being this last one also separated between the first and second categories. Volatile compounds obtained with gas chromatography could be related to the E-nose measuring and sensory analysis, being capable of matching the different defects with their correspondents' volatile compounds.
- Published
- 2022
- Full Text
- View/download PDF
24. Dynamic Fixation Techniques for the Prevention of Adjacent Segment Disease: A Retrospective Controlled Study.
- Author
-
Fuster S, Martínez-Anda JJ, Castillo-Rivera SA, Vargas-Reverón C, and Tornero E
- Abstract
Study Design: Retrospective, controlled study., Purpose: Dynamic fixation (topping-off technique) adjacent to a transforaminal lumbar interbody fusion (TLIF) level was developed to reduce the risk of adjacent segment disease (ASDi). This study was designed to compare the clinical and radiological outcomes between patients who underwent circumferential lumbar fusion (CLF) without the topping-off technique, CLF with dynamic rod constructs (DRC), and CLF with interspinous device (ISD)., Overview of Literature: Lumbar fusion can result in the re-distribution of stress, increased mobility, and increased intradiscal pressure at adjacent levels, ultimately leading to adjacent segment degeneration (ASDe) and ASDi. Dynamic fixation techniques (topping-off techniques) adjacent to vertebral fusion have been developed to reduce the risk of ASDe and ASDi because they provide a transitional zone between a caudal rigid fused segment and cephalad-mobile unfused levels., Methods: A single-center, retrospective, controlled study was designed, including all patients who underwent CLF due to degenerative lumbar spinal disease in Hospital Clinic of Barcelona between 2012 and 2018. Three groups of patients were evaluated as per the type of topping-off technique used: CLF alone group, DRC group, and ISD group. Clinical and radiological outcomes were evaluated., Results: A total of 117 patients were enrolled in the study. Sixty patients (51.3%) underwent CLF without dynamic stabilization, 24 (20.5%) were treated with DRC as topping-off technique, and 33 (28.5%) were treated with an ISD. A total of 12 patients (20.0%) in the CLF alone group showed ASDi at the final follow-up, compared to 1 (4.2%) in the DRC group (p=0.097) and 2 (6.1%) in the ISD group (p=0.127). The Cox regression model identified a significantly decreased risk of ASDi when a topping-off technique (DRC or ISD) was used (hazard ratio, 0.154; 95% confidence interval, 0.31-0.77)., Conclusions: Dynamic fixation adjacent to CLF was a safe and efficient procedure associated with improved clinical outcomes in patients with lumbar spine degenerative disease.
- Published
- 2022
- Full Text
- View/download PDF
25. Usefulness of serum D-dimer and platelet count to mean platelet volume ratio to rule out chronic periprosthetic joint infection.
- Author
-
Muñoz-Mahamud E, Tornero E, Estrada JA, Fernández-Valencia JA, Martínez-Pastor JC, and Soriano Á
- Abstract
Background : Diagnosing periprosthetic joint infection (PJI) is challenging and usually requires the evaluation of several biomarkers. Our main aim was to evaluate the usefulness of D-dimer levels as well as the platelet count (PC) to mean platelet volume (MPV) ratio serum as biomarkers to rule out chronic knee and hip infection. Methods : The study enrolled a prospective cohort of 93 patients undergoing hip or knee revision. D-dimer values, PC to MPV ratio, C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) were preoperatively determined and evaluated as a predictor of PJI. The definitive diagnosis of PJI was established according to the 2018 International Consensus Meeting criteria. Results : A total of 24 (25.8 %) cases were postoperatively diagnosed with PJI. The median D-dimer value was significantly higher ( p < 0.001) for patients with PJI (1950 ng mL - 1 ) than for patients with aseptic failure (700 ng mL - 1 ). The area under the receiver operating characteristic curves for D-dimer, CRP and ESR was 0.820, 0.793 and 0.791 respectively. D-dimer ≥ 950 ng mL - 1 (91 % sensitivity, 64 % specificity), CRP ≥ 1.95 mg dL - 1 (61 % sensitivity, 90 % specificity) and ESR > 20 (74 % sensitivity, 82 % specificity) were identified as the values with the best balance between sensitivity and specificity. The mean PC to MPV ratio was 37.0 for PJI patients and 29.8 for patients in the aseptic revision cohort ( p = 0 .067). Conclusions : Serum D-dimer levels appear very unlikely to remain normal in the presence of chronic PJI. The 91 % sensitivity when considering 950 ng mL - 1 as the threshold highlights D-dimer as the most accurate initial test to rule out chronic PJI. Conversely, the PC to MPV ratio may be of limited value for accurately diagnosing PJI., Competing Interests: The contact author has declared that neither they nor their co-authors have any competing interests., (Copyright: © 2022 Ernesto Muñoz-Mahamud et al.)
- Published
- 2022
- Full Text
- View/download PDF
26. Electronic nose application for the discrimination of sterilization treatments applied to Californian-style black olive varieties.
- Author
-
Sánchez R, Martín-Tornero E, Lozano J, Fernández A, Arroyo P, Meléndez F, and Martín-Vertedor D
- Subjects
- Least-Squares Analysis, Olive Oil analysis, Sterilization, Electronic Nose, Olea
- Abstract
Background: Olive oil continues to be the main destination for olives. The production of table olives is increasing. 'Californian-style' processes are among the most frequently employed to produce oxidized olives. Sensory evaluation requires the development of an instrumental detection method that can be used as an adjunct to traditional tasting panels., Results: An electronic nose (E-nose) was used to classify two varieties of olives following exposure to different sterilization. Principal component analysis (PCA) revealed that both varieties had different volatile profiles. Sensory panel evaluations were similar for both. Partial least squares-discriminant analysis (PLS-DA) obtained from the E-nose was able to separate the two varieties and explained 82% of total variance. Moreover, volatile profiles correctly classified olives according to sterilization times recorded up to 121 °C . The only exception was at F
0 ≥ 22 min, at which a plot of PCA outcomes failed to differentiate scores. E-nose data showed similar results to those produced from the volatile analysis when grouping samples were sterilized to F0 ≥ 18 min, at the same time distinguishing these samples from those subjected to less intense thermal treatments. A partial least squares (PLS) chemometric approach was evaluated for quantifying important olive quality parameters. With regards to validation parameters, R P 2 pertaining to perceived defect was 0.88, whilst R P 2 pertaining to overall assessment was 0.78., Conclusions: E-nose offers a fast, inexpensive and non-destructive method for discriminating between varieties and thermal treatments up to a point at which cooking defects are highly similar (from F0 = 18 onwards). © 2021 Society of Chemical Industry., (© 2021 Society of Chemical Industry.)- Published
- 2022
- Full Text
- View/download PDF
27. Characterization of Polyphenol and Volatile Fractions of Californian-Style Black Olives and Innovative Application of E-nose for Acrylamide Determination.
- Author
-
Martín-Tornero E, Sánchez R, Lozano J, Martínez M, Arroyo P, and Martín-Vertedor D
- Abstract
Californian-style black olives require a sterilization treatment that produces a carcinogenic contaminant, acrylamide. Thus, this compound was evaluated in two different olive cultivars using an electronic nose (E-nose). The sterilization intensity had a significant influence on the final phenol concentrations, acrylamide content, and volatile compounds. Increasing the sterilization intensity from 10 to 26 min (F0) reduced the phenol content, but it promoted acrylamide synthesis, leading to a wide range of this toxic substance. The Ester and phenol groups of volatile compounds decreased their content when the sterilization treatment increased; however, aldehyde and other volatile compound groups significantly increased their contents according to the thermal treatments. The compounds 4-ethenyl-pyridine, benzaldehyde, and 2,4-dimethyl-hexane are volatile compounds with unpleasant odours and demonstrated a high amount of influence on the differences found after the application of the thermal treatments. The "Manzanilla Cacereña" variety presented the highest amount of phenolic compounds and the lowest acrylamide content. Finally, it was found that acrylamide content is correlated with volatile compounds, which was determined using multiple linear regression analysis ( R
2 = 0.9994). Furthermore, the aroma of table olives was analysed using an E-nose, and these results combined with Partial Least Square (PLS) were shown to be an accurate method (range to error ratio (RER) >10 and ratio of performance to deviation (RPD) >2.5) for the indirect quantification of this toxic substance.- Published
- 2021
- Full Text
- View/download PDF
28. E-Nose Discrimination of Abnormal Fermentations in Spanish-Style Green Olives.
- Author
-
Sánchez R, Martín-Tornero E, Lozano J, Boselli E, Arroyo P, Meléndez F, and Martín-Vertedor D
- Subjects
- Humans, Spain, Electronic Nose, Fermentation, Olea metabolism
- Abstract
Current legislation in Spain indicates that table olives must be free of off-odors and off-flavors and without symptoms of ongoing alteration or abnormal fermentations. In this regard, the International Olive Council (IOC) has developed a protocol for the sensory classification of table olives according to the intensity of the predominantly perceived defect (PPD). An electronic nose (e-nose) was used to assess the abnormal fermentation defects of Spanish-style table olives that were previously classified by a tasting panel according to the IOC protocol, namely zapateria, butyric, putrid, and musty or humidity. When olives with different defects were mixed, the putrid defect had the greatest sensory impact on the others, while the butyric defect had the least sensory dominance. A total of 49 volatile compounds were identified by gas chromatography, and each defect was characterized by a specific profile. The e-nose data were analyzed using principal component analysis (PCA) and partial least square discriminant analysis (PLS-DA). The different defects were clearly separated from each other and from the control treatment, independently of PPD intensity. Moreover, the e-nose differentiated control olives from table olives with combined sensory defects despite the dilution effect resulting from the combination. These results demonstrate that e-nose can be used as an olfactory sensor for the organoleptic classification of table olives and can successfully support the tasting panel.
- Published
- 2021
- Full Text
- View/download PDF
29. Outcomes of hip arthroplasty with concomitant hardware removal: influence of the type of implant retrieved and impact of positive intraoperative cultures.
- Author
-
Madariaga S, Vargas-Reverón C, Tornero E, Alías A, Capurro B, Combalia A, Fernández-Valencia JÁ, and Muñoz-Mahamud E
- Subjects
- Bone Nails adverse effects, Bone Screws adverse effects, Humans, Retrospective Studies, Arthroplasty, Replacement, Hip adverse effects, Arthroplasty, Replacement, Hip instrumentation, Arthroplasty, Replacement, Hip mortality, Arthroplasty, Replacement, Hip statistics & numerical data, Device Removal, Prosthesis-Related Infections, Reoperation
- Abstract
Introduction: The impact of residual internal fixation devices on subsequent procedures about the hip has not been clearly well defined. The objective of the current study is to evaluate the outcome of hip arthroplasty after hardware retrieval as a one-stage replacement, to analyze possible differences related to the type of removed implant, and to assess the impact of unexpected intraoperative cultures during implant retrieval., Materials and Methods: We present a retrospective study including all those cases undergoing hip arthroplasty with concomitant hardware removal (cannulated screws, intramedullary nail, or dynamic hip screw) from 2005 to 2018. We evaluated demographics, intraoperative cultures, early infection rate, and other complications., Results: A total of 55 cases were included in the study. The median time between the implant surgery and the hip arthroplasty was 113 days. The removed devices included 6 cannulated screws, 34 intramedullary nails, and 15 dynamic hip screws. Up to 74.5% of the failed osteosynthesis belonged to intertrochanteric femoral fractures. Dislocation rate was 9.1% (1.8% requiring revision surgery), 25.5% of the cases needed further new surgeries after the hip arthroplasty, and 49.1% died during the follow-up period. Any-cause revision surgery and mortality rates were significantly increased after intramedullary nail removal. Intraoperative cultures were performed in 46 cases, and in 9 (16.4%), there was bacterial contamination: 6 cases (10.9%) presented one single positive culture and 3 (5.5%) presented ≥ 2 positive cultures for the same microorganism. A total of five cases (9.1%) presented early prosthetic joint infection that required debridement. None of these five cases had presented positive cultures at the implant removal., Conclusion: According to our results, hip arthroplasty with concomitant hardware removal is related to a high 5-year mortality rate, mainly when intramedullary nail is retrieved. Whereas a high risk of early prosthetic joint infection is associated, it seems not to be related to the elevated presence of unexpected positive cultures.
- Published
- 2021
- Full Text
- View/download PDF
30. Comprehensive analysis and ACMG-based classification of CHEK2 variants in hereditary cancer patients.
- Author
-
Vargas-Parra G, Del Valle J, Rofes P, Gausachs M, Stradella A, Moreno-Cabrera JM, Velasco A, Tornero E, Menéndez M, Muñoz X, Iglesias S, López-Doriga A, Azuara D, Campos O, Cuesta R, Darder E, de Cid R, González S, Teulé A, Navarro M, Brunet J, Capellá G, Pineda M, Feliubadaló L, and Lázaro C
- Subjects
- Base Sequence, Cohort Studies, DNA Copy Number Variations genetics, Family, Female, Gene Expression Regulation, Humans, Male, Molecular Sequence Annotation, Mutation genetics, Neoplasms pathology, Pedigree, RNA Splice Sites genetics, RNA, Messenger genetics, RNA, Messenger metabolism, Checkpoint Kinase 2 genetics, Genetic Variation, Neoplasms genetics, Societies, Scientific
- Abstract
CHEK2 variants are associated with intermediate breast cancer risk, among other cancers. We aimed to comprehensively describe CHEK2 variants in a Spanish hereditary cancer (HC) cohort and adjust the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (ACMG-AMP) guidelines for their classification. First, three CHEK2 frequent variants were screened in a retrospective Hereditary Breast and Ovarian Cancer cohort of 516 patients. After, the whole CHEK2 coding region was analyzed by next-generation sequencing in 1848 prospective patients with HC suspicion. We refined ACMG-AMP criteria and applied different combined rules to classify CHEK2 variants and define risk alleles. We identified 10 CHEK2 null variants, 6 missense variants with discordant interpretation in ClinVar database, and 35 additional variants of unknown significance. Twelve variants were classified as (likely)-pathogenic; two can also be considered "established risk-alleles" and one as "likely risk-allele." The prevalence of (likely)-pathogenic variants in the HC cohort was 0.8% (1.3% in breast cancer patients and 1.0% in hereditary nonpolyposis colorectal cancer patients). Here, we provide ACMG adjustment guidelines to classify CHEK2 variants. We hope that this study would be useful for variant classification of other genes with low effect variants., (© 2020 Wiley Periodicals LLC.)
- Published
- 2020
- Full Text
- View/download PDF
31. Improving Genetic Testing in Hereditary Cancer by RNA Analysis: Tools to Prioritize Splicing Studies and Challenges in Applying American College of Medical Genetics and Genomics Guidelines.
- Author
-
Rofes P, Menéndez M, González S, Tornero E, Gómez C, Vargas-Parra G, Montes E, Salinas M, Solanes A, Brunet J, Teulé A, Capellá G, Feliubadaló L, Del Valle J, Pineda M, and Lázaro C
- Subjects
- Adult, Aged, Alleles, Cohort Studies, Computer Simulation, DNA Copy Number Variations, Exons, Female, Genetic Predisposition to Disease genetics, Genome, Human, Genomics methods, Humans, Introns, Male, Middle Aged, Neoplastic Syndromes, Hereditary blood, Polymorphism, Single Nucleotide, Young Adult, Genetic Testing methods, High-Throughput Nucleotide Sequencing methods, Neoplastic Syndromes, Hereditary genetics, Practice Guidelines as Topic standards, RNA Splicing genetics, RNA, Messenger genetics, Sequence Analysis, RNA methods
- Abstract
RNA analyses are a potent tool to identify spliceogenic effects of DNA variants, although they are time-consuming and cannot always be performed. We present splicing assays of 20 variants that represent a variety of mutation types in 10 hereditary cancer genes and attempt to incorporate these results into American College of Medical Genetics and Genomics (ACMG) classification guidelines. Sixteen single-nucleotide variants, 3 exon duplications, and 1 single-exon deletion were selected and prioritized by in silico algorithms. RNA was extracted from short-term lymphocyte cultures to perform RT-PCR and Sanger sequencing, and allele-specific expression was assessed whenever possible. Aberrant transcripts were detected in 14 variants (70%). Variant interpretation was difficult, especially comparing old classification standards to generic ACMG guidelines and a proposal was devised to weigh functional analyses at RNA level. According to the ACMG guidelines, only 12 variants were reclassified as pathogenic/likely pathogenic because the other two variants did not gather enough evidence. This study highlights the importance of RNA studies to improve variant classification. However, it also indicates the challenge of incorporating these results into generic ACMG guidelines and the need to refine these criteria gene specifically. Nevertheless, 60% of variants were reclassified, thus improving genetic counseling and surveillance for carriers of these variants., (Copyright © 2020 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
32. Haplotype analysis of the internationally distributed BRCA1 c.3331_3334delCAAG founder mutation reveals a common ancestral origin in Iberia.
- Author
-
Tuazon AMA, Lott P, Bohórquez M, Benavides J, Ramirez C, Criollo A, Estrada-Florez A, Mateus G, Velez A, Carmona J, Olaya J, Garcia E, Polanco-Echeverry G, Stultz J, Alvarez C, Tapia T, Ashton-Prolla P, Vega A, Lazaro C, Tornero E, Martinez-Bouzas C, Infante M, De La Hoya M, Diez O, Browning BL, Rannala B, Teixeira MR, Carvallo P, Echeverry M, and Carvajal-Carmona LG
- Subjects
- Africa epidemiology, Brazil epidemiology, Chile epidemiology, Chromosomes, Human, Pair 17 genetics, Colombia epidemiology, Female, Founder Effect, Genome-Wide Association Study methods, Humans, Portugal epidemiology, Spain epidemiology, BRCA1 Protein genetics, Breast Neoplasms epidemiology, Breast Neoplasms genetics, Genetic Predisposition to Disease, Germ-Line Mutation, Haplotypes, Polymorphism, Single Nucleotide
- Abstract
Background: The BRCA1 c.3331_3334delCAAG founder mutation has been reported in hereditary breast and ovarian cancer families from multiple Hispanic groups. We aimed to evaluate BRCA1 c.3331_3334delCAAG haplotype diversity in cases of European, African, and Latin American ancestry., Methods: BC mutation carrier cases from Colombia (n = 32), Spain (n = 13), Portugal (n = 2), Chile (n = 10), Africa (n = 1), and Brazil (n = 2) were genotyped with the genome-wide single nucleotide polymorphism (SNP) arrays to evaluate haplotype diversity around BRCA1 c.3331_3334delCAAG. Additional Portuguese (n = 13) and Brazilian (n = 18) BC mutation carriers were genotyped for 15 informative SNPs surrounding BRCA1. Data were phased using SHAPEIT2, and identical by descent regions were determined using BEAGLE and GERMLINE. DMLE+ was used to date the mutation in Colombia and Iberia., Results: The haplotype reconstruction revealed a shared 264.4-kb region among carriers from all six countries. The estimated mutation age was ~ 100 generations in Iberia and that it was introduced to South America early during the European colonization period., Conclusions: Our results suggest that this mutation originated in Iberia and later introduced to Colombia and South America at the time of Spanish colonization during the early 1500s. We also found that the Colombian mutation carriers had higher European ancestry, at the BRCA1 gene harboring chromosome 17, than controls, which further supported the European origin of the mutation. Understanding founder mutations in diverse populations has implications in implementing cost-effective, ancestry-informed screening.
- Published
- 2020
- Full Text
- View/download PDF
33. Industrial Strategies to Reduce Acrylamide Formation in Californian-Style Green Ripe Olives.
- Author
-
Martín-Vertedor D, Fernández A, Mesías M, Martínez M, Díaz M, and Martín-Tornero E
- Abstract
Acrylamide, a compound identified as a probable carcinogen, is generated during the sterilization phase employed during the processing of Californian-style green ripe olives. It is possible to reduce the content of this toxic compound by applying different strategies during the processing of green ripe olives. The influence of different processing conditions on acrylamide content was studied in three olives varieties ("Manzanilla de Sevilla", "Hojiblanca", and "Manzanilla Cacereña"). Olives harvested during the yellow-green stage presented higher acrylamide concentrations than green olives. A significant reduction in acrylamide content was observed when olives were washed with water at 25 °C for 45 min (25% reduction) and for 2 h (45% reduction) prior to lye treatment. Stone olives had 21-26% higher acrylamide levels than pitted olives and 42-50% higher levels than sliced olives in the three studied varieties. When calcium chloride (CaCl
2 ) was added to the brine and brine sodium chloride (NaCl) increased from 2% to 4%, olives presented higher concentrations of this contaminant. The addition of additives did not affect acrylamide levels when olives were canned without brine. Results from this study are very useful for the table olive industry to identify critical points in the production of Californian-style green ripe olives, thus, helping to control acrylamide formation in this foodstuff.- Published
- 2020
- Full Text
- View/download PDF
34. Comparative quantification of chlorophyll and polyphenol levels in grapevine leaves sampled from different geographical locations.
- Author
-
Martín-Tornero E, de Jorge Páscoa RNM, Espinosa-Mansilla A, Martín-Merás ID, and Lopes JA
- Subjects
- Crop Production, Geography, Least-Squares Analysis, Portugal, Principal Component Analysis, Spectroscopy, Near-Infrared, Chlorophyll analysis, Models, Statistical, Plant Leaves chemistry, Polyphenols analysis, Vitis chemistry
- Abstract
Near infrared spectroscopy (NIRS) and mid-infrared spectroscopy (MIRS) in combination with chemometric analysis were applied to discriminate the geographical origin of grapevine leaves belonging to the variety "Touriga Nacional" during different vegetative stages. Leaves were collected from plants of two different wine regions in Portugal (Dão and Douro) over the grapes maturation period. A sampling plan was designed in order to obtain the most variability within the vineyards taking into account variables such as: solar exposition, land inclination, altitude and soil properties, essentially. Principal component analysis (PCA) was used to extract relevant information from the spectral data and presented visible cluster trends. Results, both with NIRS and MIRS, demonstrate that it is possible to discriminate between the two geographical origins with an outstanding accuracy. Spectral patterns of grapevine leaves show significant differences during grape maturation period, with a special emphasis between the months of June and September. Additionally, the quantification of total chlorophyll and total polyphenol content from leaves spectra was attempted by both techniques. For this purpose, partial least squares (PLS) regression was employed. PLS models based on NIRS and MIRS, both demonstrate a statistically significant correlation for the total chlorophyll (R
2 P = 0.92 and R2 P = 0.76, respectively). However, the PLS model for the total polyphenols, may only be considered as a screening method, because significant prediction errors, independently of resourcing on NIRS, MIRS or both techniques simultaneously, were obtained.- Published
- 2020
- Full Text
- View/download PDF
35. Phenylalanine Photoinduced Fluorescence and Characterization of the Photoproducts by LC-MS.
- Author
-
Martín-Tornero E, Sierra-Tadeo FJ, Durán-Merás I, and Espinosa-Mansilla A
- Subjects
- Chromatography, High Pressure Liquid instrumentation, Hydrogen Peroxide chemistry, Mass Spectrometry instrumentation, Photochemical Processes, Software, Ultraviolet Rays, Fluorescence, Fluorescent Dyes chemistry, Phenylalanine chemistry
- Abstract
Phenylalanine (Phe) is a direct precursor of tyrosine and several neurotransmitters. The accumulation of Phe in the brain generates serious and not recoverable pathologies in children. Early detection in newborns is fundamental to apply the appropriate therapy and avoid irreversible health problems. Although fluorescence is a sensitive and selective technique for the determination of amino acids, the fluorescent analysis of Phe is limited since it exhibits a very low fluorescence quantum yield; however, the fluorescence of Phe increases drastically under UV irradiation when a peroxide medium is used. The aim of this research was to analyze the effect of the UV-radiation on Phe aqueous-peroxide solutions and to study the influence of the chemical environment on the photoinducted fluorescence process. The nature and characteristics of the fluorescent photoproducts generated under off-line UV irradiation in hydrogen peroxide medium were achieved by high performance liquid chromatography (HPLC) using a spectrophotometer detector (DAD) coupled in series with a mass spectrometer (MS) or with a fast scan spectrofluorimetric detector (FSFD). Environmental characteristics such as pH, initial concentration of Phe, hydrogen peroxide amount and irradiation time were studied in order to establish their influence on the formation of each one of the photoproducts. As the formation of several highly fluorescent photoproducts has been confirmed, the possibility of designing a chromatographic system with a post-column on-line photoreactor is open. The measure of the total fluorescence signal generated from Phe at the optimized irradiation time, could be used for the determination, with high sensitivity, of the initial amount of Phe in aqueous media, such as human serum or environmental samples. These aspects are being studied at present. .
- Published
- 2019
- Full Text
- View/download PDF
36. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.
- Author
-
Parsons MT, Tudini E, Li H, Hahnen E, Wappenschmidt B, Feliubadaló L, Aalfs CM, Agata S, Aittomäki K, Alducci E, Alonso-Cerezo MC, Arnold N, Auber B, Austin R, Azzollini J, Balmaña J, Barbieri E, Bartram CR, Blanco A, Blümcke B, Bonache S, Bonanni B, Borg Å, Bortesi B, Brunet J, Bruzzone C, Bucksch K, Cagnoli G, Caldés T, Caliebe A, Caligo MA, Calvello M, Capone GL, Caputo SM, Carnevali I, Carrasco E, Caux-Moncoutier V, Cavalli P, Cini G, Clarke EM, Concolino P, Cops EJ, Cortesi L, Couch FJ, Darder E, de la Hoya M, Dean M, Debatin I, Del Valle J, Delnatte C, Derive N, Diez O, Ditsch N, Domchek SM, Dutrannoy V, Eccles DM, Ehrencrona H, Enders U, Evans DG, Farra C, Faust U, Felbor U, Feroce I, Fine M, Foulkes WD, Galvao HCR, Gambino G, Gehrig A, Gensini F, Gerdes AM, Germani A, Giesecke J, Gismondi V, Gómez C, Gómez Garcia EB, González S, Grau E, Grill S, Gross E, Guerrieri-Gonzaga A, Guillaud-Bataille M, Gutiérrez-Enríquez S, Haaf T, Hackmann K, Hansen TVO, Harris M, Hauke J, Heinrich T, Hellebrand H, Herold KN, Honisch E, Horvath J, Houdayer C, Hübbel V, Iglesias S, Izquierdo A, James PA, Janssen LAM, Jeschke U, Kaulfuß S, Keupp K, Kiechle M, Kölbl A, Krieger S, Kruse TA, Kvist A, Lalloo F, Larsen M, Lattimore VL, Lautrup C, Ledig S, Leinert E, Lewis AL, Lim J, Loeffler M, López-Fernández A, Lucci-Cordisco E, Maass N, Manoukian S, Marabelli M, Matricardi L, Meindl A, Michelli RD, Moghadasi S, Moles-Fernández A, Montagna M, Montalban G, Monteiro AN, Montes E, Mori L, Moserle L, Müller CR, Mundhenke C, Naldi N, Nathanson KL, Navarro M, Nevanlinna H, Nichols CB, Niederacher D, Nielsen HR, Ong KR, Pachter N, Palmero EI, Papi L, Pedersen IS, Peissel B, Perez-Segura P, Pfeifer K, Pineda M, Pohl-Rescigno E, Poplawski NK, Porfirio B, Quante AS, Ramser J, Reis RM, Revillion F, Rhiem K, Riboli B, Ritter J, Rivera D, Rofes P, Rump A, Salinas M, Sánchez de Abajo AM, Schmidt G, Schoenwiese U, Seggewiß J, Solanes A, Steinemann D, Stiller M, Stoppa-Lyonnet D, Sullivan KJ, Susman R, Sutter C, Tavtigian SV, Teo SH, Teulé A, Thomassen M, Tibiletti MG, Tischkowitz M, Tognazzo S, Toland AE, Tornero E, Törngren T, Torres-Esquius S, Toss A, Trainer AH, Tucker KM, van Asperen CJ, van Mackelenbergh MT, Varesco L, Vargas-Parra G, Varon R, Vega A, Velasco Á, Vesper AS, Viel A, Vreeswijk MPG, Wagner SA, Waha A, Walker LC, Walters RJ, Wang-Gohrke S, Weber BHF, Weichert W, Wieland K, Wiesmüller L, Witzel I, Wöckel A, Woodward ER, Zachariae S, Zampiga V, Zeder-Göß C, Lázaro C, De Nicolo A, Radice P, Engel C, Schmutzler RK, Goldgar DE, and Spurdle AB
- Subjects
- Alternative Splicing, Early Detection of Cancer, Female, Genetic Predisposition to Disease, Humans, Likelihood Functions, Male, Multifactorial Inheritance, Neoplasms genetics, BRCA1 Protein genetics, BRCA2 Protein genetics, Computational Biology methods, Mutation, Missense, Neoplasms diagnosis
- Abstract
The multifactorial likelihood analysis method has demonstrated utility for quantitative assessment of variant pathogenicity for multiple cancer syndrome genes. Independent data types currently incorporated in the model for assessing BRCA1 and BRCA2 variants include clinically calibrated prior probability of pathogenicity based on variant location and bioinformatic prediction of variant effect, co-segregation, family cancer history profile, co-occurrence with a pathogenic variant in the same gene, breast tumor pathology, and case-control information. Research and clinical data for multifactorial likelihood analysis were collated for 1,395 BRCA1/2 predominantly intronic and missense variants, enabling classification based on posterior probability of pathogenicity for 734 variants: 447 variants were classified as (likely) benign, and 94 as (likely) pathogenic; and 248 classifications were new or considerably altered relative to ClinVar submissions. Classifications were compared with information not yet included in the likelihood model, and evidence strengths aligned to those recommended for ACMG/AMP classification codes. Altered mRNA splicing or function relative to known nonpathogenic variant controls were moderately to strongly predictive of variant pathogenicity. Variant absence in population datasets provided supporting evidence for variant pathogenicity. These findings have direct relevance for BRCA1 and BRCA2 variant evaluation, and justify the need for gene-specific calibration of evidence types used for variant classification., (© 2019 Wiley Periodicals, Inc.)
- Published
- 2019
- Full Text
- View/download PDF
37. Does multilocus inherited neoplasia alleles syndrome have severe clinical expression?
- Author
-
Stradella A, Del Valle J, Rofes P, Feliubadaló L, Grau Garces È, Velasco À, González S, Vargas G, Izquierdo Á, Campos O, Tornero E, Navarro M, Balmaña-Gelpi J, Capellá G, Pineda M, Brunet J, and Lázaro C
- Subjects
- Adult, Aged, Biomarkers, Tumor genetics, Female, Genetic Testing, Humans, Inheritance Patterns, Male, Middle Aged, Pedigree, Severity of Illness Index, Syndrome, Alleles, Genetic Association Studies methods, Genetic Loci, Genetic Predisposition to Disease, Neoplasms diagnosis, Neoplasms genetics, Phenotype
- Abstract
Importance: Genetic testing of hereditary cancer using comprehensive gene panels can identify patients with more than one pathogenic mutation in high and/or moderate-risk-associated cancer genes. This phenomenon is known as multilocus inherited neoplasia alleles syndrome (MINAS), which has been potentially linked to more severe clinical manifestations., Objective: To determine the prevalence and clinical features of MINAS in a large cohort of adult patients with hereditary cancer homogeneously tested with the same gene panel., Patients and Methods: A cohort of 1023 unrelated patients with suspicion of hereditary cancer was screened using a validated panel including up to 135 genes associated with hereditary cancer and phakomatoses., Results: Thirteen (1.37%) patients harbouring two pathogenic mutations in dominant cancer-predisposing genes were identified, representing 5.7% (13/226) of patients with pathogenic mutations. Most (10/13) of these cases presented clinical manifestations associated with only one of the mutations identified. One case showed mutations in MEN1 and MLH1 and developed tumours associated with both cancer syndromes. Interestingly, three of the double mutants had a young age of onset or severe breast cancer phenotype and carried mutations in moderate to low-risk DNA damage repair-associated genes; two of them presented biallelic inactivation of CHEK2 . We included these two patients for the sake of their clinical interest although we are aware that they do not exactly fulfil the definition of MINAS since both mutations are in the same gene., Conclusions and Relevance: Genetic analysis of a broad cancer gene panel identified the largest series of patients with MINAS described in a single study. Overall, our data do not support the existence of more severe manifestations in double mutants at the time of diagnosis although they do confirm previous evidence of severe phenotype in biallelic CHEK2 and other DNA repair cancer-predisposing genes., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2019
- Full Text
- View/download PDF
38. Intraoperative Transfusion of Red Blood Cell Units Stored >14 Days is Associated with an Increased Risk of Prosthetic Joint Infection.
- Author
-
Tornero E, Pereira A, Basora M, Lozano L, Morata L, Muñoz-Mahamud E, Combalia A, and Soriano A
- Abstract
Background: The aim of the present study was to evaluate the association between prosthetic joint infection (PJI) after joint arthroplasty and the length of red blood cell (RBC) storage, timing of RBC transfusion, and the number of RBC units transfused. Study design and Methods: All patients who underwent a primary or revision joint artrhoplasty between January 2000 and December 2012 were retrospectively reviewed. For this study, only patients who received RBC transfusions during the day of the surgery (early transfusion group) or within the first 4 days after surgery (late transfusion group) were included. Results: A total of 9906 patients were reviewed. In the early transfusion group (n=1153, 11.6%), patients receiving 1 or 2 RBC units (3.5% vs 6.3%, P=0.041), 3 or 4 RBC (1.3% vs 13.3%, P=0.004) or ≥5 RBC units (5.0% vs 37.5%, P=0.026) had a higher PJI rate only when >50% of RBC units transfused had been stored >14 days. In the late transfusion group (n=920, 9.3%) these differences were not significant. Early transfusion of RBCs stored >14 days was an independent variable associated with an increased risk of PJI (OR:2.50, 95%CI:1.44-4.33) Conclusion: Transfusion of RBC within the first 6h after joint arthroplasty was an independent variable associated with PJI risk when RBC units are stored >14 days. The rate of PJI increased with the number of old RBC units transfused within this critical period., Competing Interests: Competing Interests: The authors have declared that no competing interest exists., (© Ivyspring International Publisher.)
- Published
- 2019
- Full Text
- View/download PDF
39. Knee Arthritis in Children: When Can It Be Safely Treated With Needle Joint Aspiration? A Large Children's Tertiary Hospital Study.
- Author
-
Tornero E, De Bergua-Domingo JM, Domenech P, Soldado F, Torner F, Castellanos J, Soriano A, and Knörr J
- Subjects
- Age Factors, Anti-Bacterial Agents therapeutic use, Arthritis, Infectious diagnosis, Arthritis, Infectious drug therapy, C-Reactive Protein analysis, Child, Preschool, Decompression, Surgical methods, Early Medical Intervention methods, Female, Hospitals, Pediatric statistics & numerical data, Humans, Infant, Male, Retrospective Studies, Treatment Outcome, Arthritis, Infectious surgery, Knee Joint pathology, Knee Joint surgery, Paracentesis methods, Time-to-Treatment
- Abstract
Background: Early joint decompression associated to antibiotic therapy is the most important procedure to reduce joint damage in septic knee arthritis in children. Several joint decompression methods have been described such as arthrotomy with open debriding, arthroscopic drainage or needle joint aspiration. The aim of the present study was to determinate which patients with acute septic knee arthritis could be safely treated with needle joint aspiration., Methods: Patients with an acute knee arthritis diagnosed between September 2003 and December 2013 in our children's tertiary hospital were retrospective review. All cases were initially treated with needle joint aspiration. Primary end-point was failure of joint aspiration., Results: A total of 74 patients were included in the study. Forty-two (56.8%) were male and median age was 1.49 years. Mean delay between onset of symptoms and diagnosis was 3.6 days and in 25 (33.8%) cases patients needed more than 1 visit to the emergency room. Median C-reactive protein (CRP) value was 36.3 mg/L and was >20 mg/L in 59 (79.7%) cases. A total of 11 (14.9%) patients showed failure of the joint aspiration treatment between 3 and 21 days after initial joint aspiration. The stepwise forward logistic regression model only identified as independent predictor of joint aspiration failure an age older than 3 years old (odds ratio, 5.64; 95% confidence interval, 1.38-29.61; P=0.018). Joint aspiration did not fail in any patient younger than 12 months and neither in any patient younger than 3 years old with CRP value <20 mg/L. Otherwise, treatment failed in 38% of patients older than 3 years and in 16% of patients between 1 and 3 years with a CRP>20 mg/L., Conclusions: Septic knee arthritis treated with needle joint aspiration succeed in all patients younger than 1 year and in all patients between 1 and 3 years with a CRP<20 mg/L. Alternative treatment such as arthroscopy debridement should be early considered in patients older than 3 years and patients between 1 and 3 years with CRP>20 mg/L., Level of Evidence: Level III.
- Published
- 2019
- Full Text
- View/download PDF
40. Phenanthrene metabolites determination in human breast and cow milk by combining elution time-emission fluorescence data with multiway calibration.
- Author
-
Martín Tornero E, Espinosa-Mansilla A, Muñoz de la Peña A, and Durán Merás I
- Subjects
- Algorithms, Animals, Calibration, Cattle, Chromatography, High Pressure Liquid methods, Environmental Pollutants chemistry, Fluorescence, Humans, Phenanthrenes chemistry, Spectrometry, Fluorescence methods, Environmental Pollutants analysis, Food Contamination analysis, Milk, Human chemistry, Phenanthrenes analysis
- Abstract
Phenanthrene is the most released polycyclic aromatic hydrocarbon into the environment by anthropogenic action. Because of the absorption and biotransformation pathways, this compound is metabolized and the most abundant metabolites are hydroxylated derivatives, such as 1-, 2-, 3-, 4- and 9-hydroxyphenanthrene, which are excreted through biological fluids, included mammals milk. For the resolution and quantitation of co-eluted analytes, elution time-emission fluorescence matrices were analysed with different second-order calibration algorithms: n-way and unfolded partial least squares, both coupled with residual bilinearization (N-PLS/RBL and U-PLS/RBL), and multivariate curve resolution-alternative least squares (MCR-ALS). Once optimized the chromatographic parameters, in isocratic mode, the elution time was of 5.5 min. The second-order data were obtained exciting at 250 nm, with an emission range from 330 to 430 nm, each 1 nm, and elution time from 0 to 5.5 min each 5.4 s. The ranges for the second-order multivariate methods in validation samples were from 1.0 to 9.0 ng mL
-1 for 1-, 2-, 3- and 4-hydroxyphenanthrene, and from 5.0 to 45.0 ng mL-1 for 9-hydroxyphenanthrene. Root mean square errors of prediction between 0.45 and 1.82 ng mL-1 (relative errors of prediction 7-22%) were obtained. The optimized procedures were applied in the analysis of human breast milk and in whole and semi-skimmed commercial cow milk. N-PLS/RBL and U-PLS/RBL algorithms show satisfactory results for the five metabolites with recoveries ranging between 82% and 115%., (Copyright © 2018 Elsevier B.V. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF
41. Predicting Failure in Early Acute Prosthetic Joint Infection Treated With Debridement, Antibiotics, and Implant Retention: External Validation of the KLIC Score.
- Author
-
Löwik CAM, Jutte PC, Tornero E, Ploegmakers JJW, Knobben BAS, de Vries AJ, Zijlstra WP, Dijkstra B, Soriano A, and Wouthuyzen-Bakker M
- Subjects
- Aged, Aged, 80 and over, Algorithms, C-Reactive Protein analysis, Female, Humans, Male, Middle Aged, Netherlands, Predictive Value of Tests, Retrospective Studies, Risk Assessment, Sensitivity and Specificity, Severity of Illness Index, Treatment Outcome, Anti-Bacterial Agents therapeutic use, Arthritis, Infectious etiology, Debridement, Hip Prosthesis adverse effects, Prosthesis-Related Infections surgery
- Abstract
Background: Debridement, antibiotics, and implant retention (DAIR) is a widely used treatment modality for early acute prosthetic joint infection (PJI). A preoperative risk score was previously designed for predicting DAIR failure, consisting of chronic renal failure (K), liver cirrhosis (L), index surgery (I), cemented prosthesis (C), and C-reactive protein >115 mg/L (KLIC). The aim of this study was to validate the KLIC score in an external cohort., Methods: We retrospectively evaluated patients with early acute PJI treated with DAIR between 2006 and 2016 in 3 Dutch hospitals. Early acute PJI was defined as <21 days of symptoms and DAIR performed within 90 days after index surgery. Failure was defined as the need for (1) second DAIR, (2) implant removal, (3) suppressive antimicrobial treatment, or (4) infection-related death within 60 days after debridement., Results: A total of 386 patients were included. Failure occurred in 148 patients (38.3%). Patients with KLIC scores of ≤2, 2.5-3.5, 4-5, 5.5-6.5, and ≥7 had failure rates of 27.9%, 37.1%, 49.3%, 54.5%, and 85.7%, respectively (P < .001). The receiver-operating characteristic curve showed an area under the curve of 0.64 (95% confidence interval 0.59-0.69). A KLIC score higher than 6 points showed a specificity of 97.9%., Conclusion: The KLIC score is a relatively good preoperative risk score for DAIR failure in patients with early acute PJI and appears to be most useful in clinical practice for patients with low or high KLIC scores., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
42. Tumor xenograft modeling identifies an association between TCF4 loss and breast cancer chemoresistance.
- Author
-
Ruiz de Garibay G, Mateo F, Stradella A, Valdés-Mas R, Palomero L, Serra-Musach J, Puente DA, Díaz-Navarro A, Vargas-Parra G, Tornero E, Morilla I, Farré L, Martinez-Iniesta M, Herranz C, McCormack E, Vidal A, Petit A, Soler T, Lázaro C, Puente XS, Villanueva A, and Pujana MA
- Subjects
- Adaptation, Physiological, Adult, Animals, Base Sequence, Breast Neoplasms drug therapy, Cell Cycle genetics, Cell Line, Tumor, Female, Genetic Heterogeneity, Humans, Mice, Mutation genetics, Prognosis, Transcription Factor 4 metabolism, Xenograft Model Antitumor Assays, Breast Neoplasms metabolism, Breast Neoplasms pathology, Drug Resistance, Neoplasm genetics, Transcription Factor 4 deficiency
- Abstract
Understanding the mechanisms of cancer therapeutic resistance is fundamental to improving cancer care. There is clear benefit from chemotherapy in different breast cancer settings; however, knowledge of the mutations and genes that mediate resistance is incomplete. In this study, by modeling chemoresistance in patient-derived xenografts (PDXs), we show that adaptation to therapy is genetically complex and identify that loss of transcription factor 4 (TCF4; also known as ITF2) is associated with this process. A triple-negative BRCA1 -mutated PDX was used to study the genetics of chemoresistance. The PDX was treated in parallel with four chemotherapies for five iterative cycles. Exome sequencing identified few genes with de novo or enriched mutations in common among the different therapies, whereas many common depleted mutations/genes were observed. Analysis of somatic mutations from The Cancer Genome Atlas (TCGA) supported the prognostic relevance of the identified genes. A mutation in TCF4 was found de novo in all treatments, and analysis of drug sensitivity profiles across cancer cell lines supported the link to chemoresistance. Loss of TCF4 conferred chemoresistance in breast cancer cell models, possibly by altering cell cycle regulation. Targeted sequencing in chemoresistant tumors identified an intronic variant of TCF4 that may represent an expression quantitative trait locus associated with relapse outcome in TCGA. Immunohistochemical studies suggest a common loss of nuclear TCF4 expression post-chemotherapy. Together, these results from tumor xenograft modeling depict a link between altered TCF4 expression and breast cancer chemoresistance., Competing Interests: Competing interestsA. Villanueva and M.A.P. are recipients of unrestricted research grants from Roche Pharma and Astellas Pharma. A. Vidal and A. Villanueva are co-founders of Xenopat. No potential conflicts of interest were disclosed by the other authors., (© 2018. Published by The Company of Biologists Ltd.)
- Published
- 2018
- Full Text
- View/download PDF
43. Improvement of the perioperative clinical management by implementation of integrated protocol of perioperative substitution of oral anticoagulants.
- Author
-
Muñoz-Corsini L, Herrero-Martin S, de la Fuente-Tornero E, Amorós-Alfonso B, and de la Lastra-Iglesias MA
- Subjects
- Administration, Oral, Ambulatory Surgical Procedures, Anticoagulants therapeutic use, Contraindications, Drug, Drug Substitution, Elective Surgical Procedures, Heparin, Low-Molecular-Weight administration & dosage, Humans, Interdisciplinary Communication, Perioperative Care education, Personnel, Hospital education, Postoperative Hemorrhage chemically induced, Postoperative Hemorrhage prevention & control, Thromboembolism prevention & control, Videoconferencing, Vitamin K administration & dosage, Anticoagulants administration & dosage, Clinical Protocols, Perioperative Care methods, Postoperative Complications prevention & control
- Published
- 2018
- Full Text
- View/download PDF
44. Correction to: Altruistic Behavior among Twins : Willingness to Fight and Self-Sacrifice for Their Closest Relatives.
- Author
-
Tornero E, Sánchez-Romera JF, Morosoli JJ, Vázquez A, Gómez Á, and Ordoñana JR
- Abstract
The original version of this article unfortunately contained a mistake. The presentation of the article title and subtitle was incorrect.
- Published
- 2018
- Full Text
- View/download PDF
45. Altruistic Behavior among Twins : Willingness to Fight and Self-Sacrifice for Their Closest Relatives.
- Author
-
Tornero E, Sánchez-Romera JF, Morosoli JJ, Vázquez A, Gómez Á, and Ordoñana JR
- Subjects
- Adult, Female, Humans, Male, Aggression psychology, Altruism, Sibling Relations, Twins, Dizygotic psychology, Twins, Monozygotic psychology
- Abstract
According to kin selection theory, indirect reproductive advantages may induce individuals to care for others with whom they share genes by common descent, and the amount of care, including self-sacrifice, will increase with the proportion of genes shared. Twins represent a natural situation in which this hypothesis can be tested. Twin pairs experience the same early environment because they were born and raised at the same time and in the same family but their genetic relatedness differs depending on zygosity. We compared the degree of willingness to fight and sacrifice for the co-twin among monozygotic (MZ) and dizygotic (DZ) pairs in a sample of 1443 same-sex and opposite-sex twins. We also analyzed the effect of the subject's gender and that of the co-twin on those altruistic behaviors. Results partly supported the postulated explanation. MZ twins (who share nearly their entire genome) were significantly more likely than DZ twins (who on average share half of their segregating genes) to self-sacrifice for their co-twins, but zygosity did not affect willingness to fight for him/her. The genders of the subject and of the co-twin, not genetic relatedness, were the best predictors of aggressive altruistic intentions.
- Published
- 2018
- Full Text
- View/download PDF
46. The 2017 Cervical Spine Research Society International Traveling Fellowship.
- Author
-
Mesfin A, Zhou F, Scemama C, Kaito T, Tornero E, and Nassr A
- Subjects
- Biomedical Research, Humans, Travel, Cervical Vertebrae, Fellowships and Scholarships, Societies, Medical, Spinal Diseases surgery
- Published
- 2018
- Full Text
- View/download PDF
47. Moxifloxacin plus rifampin as an alternative for levofloxacin plus rifampin in the treatment of a prosthetic joint infection with Staphylococcus aureus.
- Author
-
Wouthuyzen-Bakker M, Tornero E, Morata L, Nannan Panday PV, Jutte PC, Bori G, Kampinga GA, and Soriano A
- Subjects
- Aged, Drug Therapy, Combination, Female, Humans, Male, Microbial Sensitivity Tests, Moxifloxacin, Prosthesis-Related Infections microbiology, Retrospective Studies, Staphylococcal Infections microbiology, Treatment Outcome, Anti-Bacterial Agents therapeutic use, Fluoroquinolones therapeutic use, Levofloxacin therapeutic use, Prosthesis-Related Infections drug therapy, Rifampin therapeutic use, Staphylococcal Infections drug therapy, Staphylococcus aureus drug effects
- Abstract
Objectives: The combination of a fluoroquinolone with rifampin is one of the cornerstones in the treatment of prosthetic joint infections (PJI) caused by staphylococci. Moxifloxacin is highly active against methicillin-susceptible Staphylococcus aureus (MSSA) and, therefore, is an attractive agent to use. However, several studies reported a lowering in serum moxifloxacin levels when combined with rifampin. The clinical relevance remains unclear. We determined the outcome of patients with early acute PJI caused by MSSA treated with either moxifloxacin/rifampin or levofloxacin/rifampin., Methods: Medical files of patients treated with moxifloxacin/rifampin (University Medical Centre Groningen) or levofloxacin/rifampin (Hospital Clinic Barcelona) were retrospectively reviewed (2005-2015). Treatment failure was defined as the need for revision surgery and/or suppressive therapy, death by infection or a relapse of infection during follow-up., Results: Differences in baseline characteristics between the two cohorts were observed, but prognostic parameters for failure, as defined by the KLIC-score (Kidney failure, Liver cirrhosis, Index surgery, C-reactive protein and Cemented prosthesis), were similar in the two groups (2.9 [1.5 SD] for the moxifloxacin group vs. 2.2 [1.2 SD] for the levofloxacin group [P = 0.16]). With a mean follow-up of 50 months (36 SD) in the moxifloxacin group, and 67 months (50 SD) in the levofloxacin group (P = 0.36), treatment was successful in 89% vs. 87.5%, respectively (P = 0.89). None of the failures in the moxifloxacin group were due to rifampin- or moxifloxacin-resistant S. aureus strains., Conclusion: Our data indicate that moxifloxacin combined with rifampin is as clinically effective as levofloxacin/rifampin for early acute PJI caused by MSSA., (Copyright © 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
48. Withholding Preoperative Antibiotic Prophylaxis in Knee Prosthesis Revision: A Retrospective Analysis on Culture Results and Risk of Infection.
- Author
-
Wouthuyzen-Bakker M, Tornero E, Claret G, Bosch J, Martinez-Pastor JC, Combalia A, and Soriano A
- Subjects
- Aged, Aged, 80 and over, Female, Follow-Up Studies, Humans, Knee Joint microbiology, Knee Joint surgery, Male, Prosthesis-Related Infections etiology, Prosthesis-Related Infections microbiology, Reoperation, Retrospective Studies, Risk Factors, Antibiotic Prophylaxis methods, Arthroplasty, Replacement, Knee adverse effects, Microbiological Techniques methods, Prosthesis-Related Infections diagnosis
- Abstract
Background: A significant amount of patients undergoing revision surgery of a prosthetic joint turn out to have an infection. Withholding preoperative antibiotic prophylaxis in these patients to optimize culture yield during revision surgery remains a matter of debate. The aim of our study was to determine (1) the rate of positive intraoperative cultures with or without preoperative antibiotic prophylaxis and (2) the incidence of a prosthetic joint infection (PJI) during the follow-up in the 2 groups., Methods: Medical files of patients in whom preoperative antibiotic prophylaxis was withheld until culture samples were taken (2007-2010, n = 284) and in whom antibiotic prophylaxis was given during the induction of anesthesia (2010-2013, n = 141) were retrospectively reviewed., Results: The percentage of ≥1 positive cultures was the same in the group without (26%) and with preoperative prophylaxis (27%; P value, .7). PJI was diagnosed during revision surgery according to the Musculoskeletal Infection Society criteria in 6.7% patients not receiving preoperative prophylaxis and in 7.0% receiving it (P value, .79). We found no important differences in the type of microorganisms that were isolated in both groups. During a 3-month follow-up, an early PJI developed in patients undergoing total revision surgery in 6.4% of the nonpreoperative prophylaxis group vs 1.6% in the preoperative prophylaxis group (P value, .1)., Conclusion: Preoperative antibiotic prophylaxis does not reduce culture yield in patients undergoing knee revision surgery. Our data show a trend toward a higher PJI rate in the postoperative period of total revision surgery when preoperative prophylaxis is withheld., (Copyright © 2017 Elsevier Inc. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
49. Kounis Syndrome During Anesthesia: Presentation of Indolent Systemic Mastocytosis: A Case Report.
- Author
-
de la Fuente Tornero E, Vega Castro A, de Sierra Hernández PÁ, Balaguer Recena J, Zaragoza Casares SC, Serrano Baylin FM, Gallardo Culebradas P, Amorós Alfonso B, and Rodríguez Fraile JR
- Subjects
- Gelatin administration & dosage, Hemodynamics drug effects, Humans, Infusions, Intravenous, Kounis Syndrome diagnosis, Kounis Syndrome physiopathology, Kounis Syndrome therapy, Male, Mastocytosis, Systemic diagnosis, Mastocytosis, Systemic physiopathology, Mastocytosis, Systemic therapy, Middle Aged, Orthopedic Procedures, Plasma Substitutes administration & dosage, Risk Factors, Succinates administration & dosage, Anesthesia, General adverse effects, Gelatin adverse effects, Kounis Syndrome etiology, Mastocytosis, Systemic chemically induced, Plasma Substitutes adverse effects, Succinates adverse effects
- Abstract
Mastocytosis comprises a heterogeneous group of disorders characterized by mast cell accumulation and proliferation in distinct organs. Kounis syndrome is defined as the concurrence of acute coronary syndromes with mast cell activation in a setting of allergic or hypersensitivity reactions. This is the first reported case of an intraoperative Kounis syndrome as the onset of an indolent systemic mastocytosis probably triggered by succinylated gelatin infusion during general anesthesia. The presentation of this case is intended to contribute to the knowledge of mastocytosis and Kounis syndrome at the time of diagnostic workup during intraoperative anaphylaxis or myocardial ischemia.
- Published
- 2017
- Full Text
- View/download PDF
50. A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape.
- Author
-
Castellanos E, Gel B, Rosas I, Tornero E, Santín S, Pluvinet R, Velasco J, Sumoy L, Del Valle J, Perucho M, Blanco I, Navarro M, Brunet J, Pineda M, Feliubadaló L, Capellá G, Lázaro C, and Serra E
- Subjects
- High-Throughput Nucleotide Sequencing methods, Humans, Sensitivity and Specificity, Early Detection of Cancer methods, Genetic Testing methods, Molecular Diagnostic Techniques methods, Neoplastic Syndromes, Hereditary diagnosis, Neoplastic Syndromes, Hereditary genetics
- Abstract
We wanted to implement an NGS strategy to globally analyze hereditary cancer with diagnostic quality while retaining the same degree of understanding and control we had in pre-NGS strategies. To do this, we developed the I2HCP panel, a custom bait library covering 122 hereditary cancer genes. We improved bait design, tested different NGS platforms and created a clinically driven custom data analysis pipeline. The I2HCP panel was developed using a training set of hereditary colorectal cancer, hereditary breast and ovarian cancer and neurofibromatosis patients and reached an accuracy, analytical sensitivity and specificity greater than 99%, which was maintained in a validation set. I2HCP changed our diagnostic approach, involving clinicians and a genetic diagnostics team from panel design to reporting. The new strategy improved diagnostic sensitivity, solved uncertain clinical diagnoses and identified mutations in new genes. We assessed the genetic variation in the complete set of hereditary cancer genes, revealing a complex variation landscape that coexists with the disease-causing mutation. We developed, validated and implemented a custom NGS-based strategy for hereditary cancer diagnostics that improved our previous workflows. Additionally, the existence of a rich genetic variation in hereditary cancer genes favors the use of this panel to investigate their role in cancer risk.
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.